ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

15,999Medicare Part D Prescriptions Filled, Including Refills

Rank: 49 out of 2456

$886K Total Retail Price of All Prescriptions

Rank: 60 out of 2456

814 Patients Receiving at Least One Drug in Part D
66%Patients 65 Years and Older
71% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Massachusetts
Lower avg

Schedule Two
Controlled Substances

4% of this provider’s 814 patients filled at least one prescription for a schedule two drug, compared to an average of 6%.

Schedule Three
Controlled Substances

9% of this provider’s 814 patients filled at least one prescription for a schedule three drug, compared to an average of 5%.

Risky Drugs to Seniors

3% of this provider’s 10,599 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

22% of this provider’s prescriptions were for brand-name drugs, compared to an average of 22%.

Prescription Price

$55 was the average price of a prescription from this provider, compared to $56 among peers.

Prescriptions per Patient

20 is the average number of prescriptions (including refills) per patient, compared to an average of 18.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Massachusetts
LISINOPRIL 903 594 1 1
OMEPRAZOLE 828 534 2 3
SIMVASTATIN 823 593 3 2
AMLODIPINE BESYLATE 524 413 4 5
LEVOTHYROXINE SODIUM 453 289 5 4
FUROSEMIDE 445 374 6 8
METFORMIN HCL ER 385 217 7 59
CRESTOR 380 293 8 25
CITALOPRAM HBR 300 148 9 14
LABETALOL HCL 294 212 10 128
CARVEDILOL 288 195 11 54
ALENDRONATE SODIUM 254 193 12 19
ALLOPURINOL 245 184 13 27
PANTOPRAZOLE SODIUM 244 173 14 37
GLYBURIDE 211 125 R 15 40
MECLIZINE HCL 188 130 16 107
LOSARTAN POTASSIUM 185 148 17 18
FLUOXETINE HCL 177 94 18 45
WARFARIN SODIUM 175 111 19 9
HYDROCHLOROTHIAZIDE 169 87 20 7
METOPROLOL TARTRATE 168 153 21 10
TAMSULOSIN HCL 165 137 22 32
SERTRALINE HCL 154 116 23 21
CALCITRIOL 151 90 24 153
LISINOPRIL-HYDROCHLOROTHIAZIDE 150 86 25 41
ATORVASTATIN CALCIUM 148 82 26 12
HYDROCODONE-ACETAMINOPHEN 142 80 S3 27 20
ATENOLOL 139 119 28 6
CLOPIDOGREL 134 121 29 55
AMITRIPTYLINE HCL 131 58 R 30 83
PROAIR HFA 128 72 31 22
PLAVIX 127 120 32 79
FENOFIBRATE 124 69 33 68
GABAPENTIN 119 60 34 16
NIFEDIPINE ER 111 95 35 61
GLYBURIDE-METFORMIN HCL 110 94 R 36 238
SPIRIVA 105 83 37 43
LANTUS 105 94 37 44
TRIAMTERENE-HCTZ 103 54 39 53
CYMBALTA 96 41 40 65
COMBIVENT 93 40 41 132
POLYETHYLENE GLYCOL 3350 89 72 42 64
METFORMIN HCL 89 50 42 11
LANTUS SOLOSTAR 89 45 42 136
ADVAIR DISKUS 88 50 45 36
NEXIUM 87 33 46 80
PRAVASTATIN SODIUM 87 54 46 15
INDAPAMIDE 85 61 48 254
CIPROFLOXACIN HCL 84 64 49 87
LOSARTAN-HYDROCHLOROTHIAZIDE 83 53 50 117
TRAMADOL HCL 82 50 51 24
FAMOTIDINE 81 79 52 84
ACETAMINOPHEN-CODEINE 78 63 S3 53 106
SINGULAIR 73 34 54 149
PAROXETINE HCL 72 40 55 56
ONGLYZA 69 54 56 254
QUETIAPINE FUMARATE 69 33 56 47
KLOR-CON M20 69 58 56 69
DEXILANT 67 17 59 114
ZOLPIDEM TARTRATE 65 51 60 28
IBUPROFEN 64 16 61 52
LEVOFLOXACIN 63 38 62 103
METOPROLOL SUCCINATE 63 39 62 13
INSULIN SYRINGE 62 54 64 72
LEVEMIR FLEXPEN 61 28 65 214
LIDODERM 58 49 66 58
HYDRALAZINE HCL 54 39 67 105
JANTOVEN 54 48 67 303
ISOSORBIDE MONONITRATE ER 54 43 67 48
METOCLOPRAMIDE HCL 54 27 67 170
MIRTAZAPINE 51 35 71 29
POTASSIUM CHLORIDE 50 29 72 33
DONEPEZIL HCL 50 38 72 23
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Oct. 16, 2008.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.